OneBio Venture Studio Makes Second Investment Into Yemaachi Biotech
OneBio Venture Studio is proud to announce its second investment from Fund II into Yemaachi Biotech, a Ghana-based genomics company building the world’s most diverse cancer bio-database to develop next-generation cancer drugs that work across diverse populations. Yemaachi Biotech‘s work is rooted in a simple but powerful conviction: precision oncology research, diagnostics, and therapeutics must […]